Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1199

1.

Renal function, acute kidney injury and hospital mortality in patients with acute myocardial infarction.

Liao Y, Dong X, Chen K, Fang Y, Li W, Huang G.

J Int Med Res. 2014 Jul 22. pii: 0300060514541254. [Epub ahead of print]

PMID:
25053800
[PubMed - as supplied by publisher]
2.

Renal Function-Adjusted Contrast Volume Redefines the Baseline Estimation of Contrast-Induced Acute Kidney Injury Risk in Patients Undergoing Primary Percutaneous Coronary Intervention.

Andò G, de Gregorio C, Morabito G, Trio O, Saporito F, Oreto G.

Circ Cardiovasc Interv. 2014 Jul 15. pii: CIRCINTERVENTIONS.114.001545. [Epub ahead of print]

PMID:
25027519
[PubMed - as supplied by publisher]
3.

P669High pressure perfusion augments infarct size through a ROS dependent mechanism, protection by allopurinol.

Ytrehus K, Boardman N, Martin-Armas M, Norvik J, Jensen T, Toft I.

Cardiovasc Res. 2014 Jul 15;103 Suppl 1:S122. doi: 10.1093/cvr/cvu098.94. Epub 2014 Jun 27.

PMID:
25020397
[PubMed - in process]
4.

Does percutaneous nephrolithotomy cause elevated cardiac troponins?

Shemirani H, Khanjani R, Mohammadi-Sichani M, Mozafarpour S, Rabbani M, Shahabi J.

ARYA Atheroscler. 2014 Jan;10(1):41-5.

PMID:
24963313
[PubMed]
Free PMC Article
5.

Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Lekawanvijit S, Krum H.

J Physiol. 2014 Jun 6. [Epub ahead of print] Review.

PMID:
24907309
[PubMed - as supplied by publisher]
6.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; The SPRINT Study Research Group.

Clin Trials. 2014 Jun 5. pii: 1740774514537404. [Epub ahead of print]

PMID:
24902920
[PubMed - as supplied by publisher]
7.

Therapeutic translation in acute kidney injury: the epithelial/endothelial axis.

Molitoris BA.

J Clin Invest. 2014 Jun 2;124(6):2355-63. doi: 10.1172/JCI72269. Epub 2014 Jun 2.

PMID:
24892710
[PubMed - in process]
8.

Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction.

Liu KL, Lee KT, Chang CH, Chen YC, Lin SM, Chu PH.

Crit Care. 2014 May 16;18(3):R100. doi: 10.1186/cc13876.

PMID:
24886544
[PubMed - in process]
Free PMC Article
9.

[Problems in the diagnosis of acute kidney injury in patients with ST-segment elevation myocardial infarction].

Menzorov MV, Shutov AM, Makeeva ER, Serov VA, Mikhaĭlova EV, Parfenova EA.

Ter Arkh. 2014;86(4):25-9. Russian.

PMID:
24864464
[PubMed - indexed for MEDLINE]
10.

Biomarkers in cardiorenal syndromes.

Tan K, Sethi SK.

Transl Res. 2014 Aug;164(2):122-134. doi: 10.1016/j.trsl.2014.04.011. Epub 2014 Apr 24. Review.

PMID:
24831739
[PubMed - as supplied by publisher]
11.

Acute kidney injury and acute myocardial infarction.

Ebina T, Kosuge M, Kimura K.

Circ J. 2014;78(6):1329-30. Epub 2014 May 7. No abstract available.

PMID:
24805356
[PubMed - in process]
Free Article
12.

Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.

Bangalore S, Fayyad R, Hovingh GK, Laskey R, Vogt L, DeMicco DA, Waters DD; Treating to New Targets Steering Committee and Investigators.

Am J Cardiol. 2014 Jun 15;113(12):2018-20. doi: 10.1016/j.amjcard.2014.03.046. Epub 2014 Apr 3. Review.

PMID:
24793673
[PubMed - indexed for MEDLINE]
13.

Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class.

Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K; AMI-Kyoto Multi-Center Risk Study Group.

Intern Med. 2014;53(9):933-9. Epub 2014 May 1.

PMID:
24785883
[PubMed - in process]
Free Article
14.

Changes in diabetes-related complications in the United States, 1990-2010.

Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L.

N Engl J Med. 2014 Apr 17;370(16):1514-23. doi: 10.1056/NEJMoa1310799.

PMID:
24738668
[PubMed - indexed for MEDLINE]
15.

Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.

Watabe H, Sato A, Hoshi T, Takeyasu N, Abe D, Akiyama D, Kakefuda Y, Nishina H, Noguchi Y, Aonuma K.

Int J Cardiol. 2014 Jun 1;174(1):57-63. doi: 10.1016/j.ijcard.2014.03.146. Epub 2014 Mar 28.

PMID:
24726211
[PubMed - in process]
16.

Differential effects of commercial-grade and purified poloxamer 188 on renal function.

Emanuele M, Balasubramaniam B.

Drugs R D. 2014 Jun;14(2):73-83. doi: 10.1007/s40268-014-0041-0.

PMID:
24723148
[PubMed - in process]
Free PMC Article
17.

Survival after repair of pararenal and paravisceral abdominal aortic aneurysms.

Kabbani LS, West CA, Viau D, Nypaver TJ, Weaver MR, Barth C, Lin JC, Shepard AD.

J Vasc Surg. 2014 Jun;59(6):1488-94. doi: 10.1016/j.jvs.2014.01.008. Epub 2014 Apr 4.

PMID:
24709440
[PubMed - indexed for MEDLINE]
18.

Admission hyperglycemia is an independent predictor of acute kidney injury in patients with acute myocardial infarction.

Moriyama N, Ishihara M, Noguchi T, Nakanishi M, Arakawa T, Asaumi Y, Kumasaka L, Kanaya T, Miyagi T, Nagai T, Yamane T, Fujino M, Honda S, Fujiwara R, Anzai T, Kusano K, Goto Y, Yasuda S, Ogawa H.

Circ J. 2014;78(6):1475-80. Epub 2014 Apr 3.

PMID:
24694768
[PubMed - in process]
Free Article
19.

The most relevant complications of transcatheter aortic valve implantation according to VARC criteria.

Neragi-Miandoab S, Salemi A.

Minerva Cardioangiol. 2014 Apr;62(2):205-20.

PMID:
24686998
[PubMed - in process]
20.

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.

PMID:
24682069
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk